UBS
UBS Confirms Rating for Summit Therapeutics Shares
UBS confirmed the rating for Summit Therapeutics shares, indicating confidence in the company's future prospects.
UBS Analysts Forecast Profit Growth for Chinese Tech Platforms
Major Chinese technology companies are set to become significantly more profitable in the near future.